May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs, announced today that Jan-Anders Karlsson, PhD, CEO of Verona Pharma, is scheduled to present at the Jefferies 2017 Global Healthcare Conference.
An audio webcast of the presentation will be available on the Investors section of the company website, www.veronapharma.com . A replay of the webcast will be made available for 90 days following the presentation.
Event: Jefferies Healthcare Conference
Date: June 8, 2017
Time: 11:30 AM EDT
Location: New York, NY
For further information, please contact:
|Verona Pharma plc||Tel: +44 (0)20 3283 4200|
|Jan-Anders Karlsson, Chief Executive Officerfirstname.lastname@example.org|
|N+1 Singer (Nominated Adviser and UK Broker)||Tel: +44 (0)20 7496 3000|
|Aubrey Powell / James White|
|FTI Consulting (UK Media and Investor enquiries)||Tel: +44 (0)20 3727 1000|
Simon Conway / Stephanie Cuthbert /
|ICR, Inc. (US Media and Investor enquiries)|
Tel: +1 203-682-8251
Tel. +1 646-277-1282